American Society of Nephrology
1510 H Street, NW
144 articles with American Society of Nephrology
The American Society of Nephrology and the National Kidney Foundation announce the concurrent publication of "Special Article: Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force" in the Journal of the American Society of Nephrology and the American Journal of Kidney Diseases.
The U.S. Department of Health and Human Services and the American Society of Nephrology have named Outset Medical’s Tablo Hemodialysis System® one of seven winners in Round 2 of the KidneyX COVID-19 Kidney Care Challenge, recognizing innovative solutions for safely delivering kidney care during the pandemic.
American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health Event Featuring Leading Clinicians, Biotech Innovators and Federal Health Agencies to Highlight Innovation and Opportunity in Kidney Health
Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney diseases to drive improved patient outcomes and advance value-based care, announced today that it will co-host a Capital Markets Day for Kidney Health with the American Society of Nephrology (ASN) on Thursday, February 11 from 8:00 a.m. — 12:30 p.m. EST. The virtual event will bring
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Cardiovascular Events in Patients with Compromised Renal Function at Baseline in Prespecified and Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at ASN Kidney Week 2020
Patients with decreased renal function prior to treatment with VASCEPA or placebo had higher rates of cardiovascular events than the overall population studied in REDUCE-IT
Nationwide Kidney Risk Campaign Relaunches by National Kidney Foundation, U.S. Department of Health and Human Services, and American Society of Nephrology
The National Kidney Foundation is joining forces with the U.S. Department of Health and Human Services, the American Society of Nephrology, and actor, activist and entrepreneur Wilmer Valderrama to reach the 1 in 3 American adults at risk for kidney disease.
New Kidney360 Publication Highlights CareDx’s AlloSure is Differentiated as the dd-cfDNA Test of ChoiceHead to head data shows that not all dd-cfDNA is the same
CareDx, Inc. announces that the journal of the American Society of Nephrology, Kidney360, published a study evaluating AlloSure simultaneously with a different donor-derived cell-free DNA monitoring tool for allograft rejection.
Nation's Largest Kidney Patient and Professional Organizations Urge Action to Protect Patients During Reopening
The National Kidney Foundation and American Society of Nephrology join to advance the unique needs of kidney patients during COVID-19
The U.S. Department of Health and Human Services, American Society of Nephrology and National Kidney Foundation announced that 25 innovators have been selected as winners in two categories of the first-ever KidneyX: Patient Innovator Challenge, funded by NKF.
Nationwide Kidney Risk Campaign Launched by National Kidney Foundation, U.S. Department of Health and Human Services, and American Society of Nephrology
The National Kidney Foundation is joining forces with the U.S. Department of Health and Human Services, the American Society of Nephrology, and actor Wilmer Valderrama to reach the 1 in 3 American adults at risk for kidney disease.
HHS and the American Society of Nephrology Launch $1.5 Million Phase 2 of Prize Competition to Redesign Dialysis
KidneyX seeks breakthrough solutions to transform kidney care
CareDx, Inc. announces CareDx presence at the American Society of Nephrology Kidney Week taking place in Washington D.C. November 5-10, 2019.
DaVita clinical leaders push for innovation through new research
Horizon Therapeutics plc Brings Gout-Kidney Link into Focus during American Society of Nephrology (ASN) Kidney Week 2019
Research, interactive features and charitable opportunity support advancement of care
Presentations at ASN Kidney Week 2019 Highlight Breadth of ChemoCentryx Platform in Treatment of Complement 3 Glomerulopathy (C3G) and Focal Segmental Glomerulosclerosis (FSGS)
Highlights Study Design, Outcome Measures, and Baseline Patient Data in the Ongoing Avacopan ACCOLADE Phase II Trial in C3G
The U.S. Department of Health and Human Services Office of the Chief Technology Officer and the American Society of Nephrology have selected 15 winning teams for Phase 1 of the KidneyX Redesign Dialysis prize competition.
In a phase 3 clinical trial, tenapanor significantly lowered elevated blood phosphate in patients receiving maintenance hemodialysis, resulting in an average reduction of 1.0–1.2 mg/dL over 8 weeks.
Lower Hospitalization Rates Observed Among Patients New to Hemodialysis with Relative Blood Volume Monitoring Utilizing Crit-Line®
Researchers Discuss Benefits of Fluid Management for Dialysis Patients at the American Society of Nephrology's 2018 Kidney Week Symposium.
Dimerix Limited To Present Analysis Of DMX-200 Phase IIa Clinical Trial In Chronic Kidney Disease At The American Society of Nephrology (ASN) Annual Kidney Week 2017
Retrophin Reports Additional Positive Data From Phase II DUET Study Of Sparsentan In Focal Segmental Glomerulosclerosis At American Society of Nephrology Kidney Week 2016